MycoBiomDB – Record Details (MyCo_2973)

Biomarker Record Details

Database ID: MyCo_2973
DB IDMyCo_2973
TitleHigh prevalence of peribronchial focal lesions of airway invasive aspergillosis in hematological cancer patients with prolonged neutropenia
Year2020
PMID32462888
Fungal Diseases involvedInvasive aspergillosis
Associated Medical ConditionHematological cancer patients with prolonged neutropenia
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomannan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationSwitzerland
Cohort35 patients were identified.
Cohort No.35
Age Group22–79
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive pulmonary aspergillosis (IPA) is a life-¬ threatening infection affecting hematological cancer patients with chemotherapy-¬ induced neutropenia. CT-¬ scan imaging plays a critical role in IPA diagnosis. In neutropenic patients, well-¬ circumscribed lesions with or without the halo sign are highly suggestive findings of IPA, according to European Organization for Research and Treatment of Cancer and Mycoses Study Group (EORTC/MSG) diag- nostic criteria. Conversely, peribronchial consolidations are classically described in airway invasive aspergillosis in non-¬ hematological cancer patients.
TechniqueELISA
Analysis MethodFDA Approved -Platelia Aspergillus ELISA
ELISA kitsELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA; Bio-Rad Laboratories, Redmond, WA, USA)
Assay DataNone
Validation Techniques usedFDA Approved -Platelia Aspergillus ELISA
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone